Clinical Chemistry, Malmö
491 – 500 of 1328
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Ligands for C1q and factor H on the surface of apoptotic cells
(
- Contribution to journal › Published meeting abstract
-
Mark
A Common Prostate Cancer Risk Variant 5 ' of Microseminoprotein-beta (MSMB) Is a Strong Predictor of Circulating beta-Microseminoprotein (MSP) Levels in Multiple Populations
(
- Contribution to journal › Article
-
Mark
Mouse ApoM Displays an Unprecedented Seven-Stranded Lipocalin Fold: Folding Decoy or Alternative Native Fold?
(
- Contribution to journal › Article
-
Mark
Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
-
Mark
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Polymorphisms at the Microseminoprotein-beta Locus Associated with Physiologic Variation in beta-Microseminoprotein and Prostate-Specific Antigen Levels
(
- Contribution to journal › Article
-
Mark
HLA Class I and Genetic Susceptibility to Type 1 Diabetes Results From the Type 1 Diabetes Genetics Consortium
(
- Contribution to journal › Article
-
Mark
Miniaturised and Quantitative Techniques Targeting Prostate Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION
2010) 78th Congress of the European-Atherosclerosis-Society In Atherosclerosis Supplements 11(2). p.233-233(
- Contribution to journal › Published meeting abstract